SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
| | | | | |
| Date of Report (Date of earliest event reported) | | September 26, 2003 | | |
| | |
| | |
EPOCH BIOSCIENCES, INC.
(Exact name of Registrant as specified in charter)
| | | | | |
| Delaware | | 0-22170 | | 91-1311592 |
|
(State or other jurisdiction
of incorporation) | | (Commission
File Number) | | (I.R.S. Employer
Identification No.) |
| | | |
| 21720 23rd Drive S.E., Suite 150, Bothell, Washington | | 98021 |
|
| (Address of principal executive offices) | | (Zip Code) |
| | | | | |
| Registrant’s telephone number, including area code | | (425) 482-5555 | | |
| | |
| | |
(Former name or former address, if changed, since last report.)
TABLE OF CONTENTS
Item 5. Other Events
On September 26, 2003, Epoch Biosciences, Inc. issued a press release announcing that it was not awarded a contract with the United States Department of Defense to provide Block 1 of the Joint Biological Agent Identification and Diagnostic Systems (JBAIDS). The press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Item 7. Exhibits
| | | |
| Exhibit | | |
| Number | | |
| | |
| 99.1 | | Press release dated September 26, 2003 |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.
| | | | | |
| | | EPOCH BIOSCIENCES, INC. |
| | | | | |
| Date: September 30, 2003 | | By: | | /s/ Bert W. Hogue |
| | | | |
|
| | | | | Bert W. Hogue |
| | | | | Vice President and |
| | | | | Chief Financial Officer |
EXHIBIT INDEX
The following exhibits are attached hereto and incorporated herein by reference:
| | | |
| Exhibit | | |
| Number | | |
| | |
| 99.1 | | Press release dated September 26, 2003 |
